Hamburg, Germany

Nikolaus Machuy

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2006-2015.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Berlin, DE (2006)
  • Hamburg, DE (2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nikolaus Machuy

Introduction

Nikolaus Machuy is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of influenza research. With a total of 2 patents, Machuy's work focuses on developing innovative solutions to combat viral infections.

Latest Patents

One of Machuy's latest patents is centered around influenza targets. This invention relates to a pharmaceutical composition that includes an inhibitor of influenza virus replication. Additionally, it presents a screening method for identifying new targets for the prevention, alleviation, or treatment of influenza. Another notable patent involves novel proteins with cytotoxic activity derived from the sea hare, showcasing his diverse research interests.

Career Highlights

Machuy is affiliated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its cutting-edge scientific work. His role within this organization allows him to collaborate with leading scientists and contribute to groundbreaking research in his field.

Collaborations

Some of Machuy's notable coworkers include Thomas F. Meyer and Daniel Butzke. Their collaborative efforts enhance the research environment and foster innovation in the study of viral infections.

Conclusion

Nikolaus Machuy's contributions to the field of pharmaceuticals, particularly in influenza research, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to finding effective solutions for viral infections, making him a valuable figure in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…